Document is current
Any future updates will be listed below
-
Authors
Moura, João https://orcid.org/0000-0002-4212-906X
Granziera, Cristina
Marta, Monica
Silva, Ana Martins
- License Information
-
More Information
Article History
Received: 21 December 2023
Accepted: 13 February 2024
First Online: 19 February 2024
Declarations
:
: None.
: None.
: João Moura received support to attend scientific conferences/meetings from Orphalan, Sanofi, Novartis, UCB, Alnylam and Alexion.Cristina Granziera—The University Hospital Basel (USB) and the Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), as the employer of C.G., have received the following fees which were used exclusively for research support: (i) advisory boards and consultancy fees from Actelion, Novartis, Genzyme-Sanofi, GeNeuro, Hoffmann La Roche, Janssen, Merck, Biogen and Siemens; (ii) speaker fees from Biogen, Hoffmann La Roche, Teva, Novartis, Jannsen, Merck and Genzyme-Sanofi; (iii) research grants: Hoffmann La Roche, GeNeuro, Novartis, Genzyme-Sanofi and Biogen.Mónica Marta received support to attend scientific conferences/meetings from Novartis and Merck.Ana Martins Silva has received compensation as a speaker in meetings and for consulting, clinical trial research, and advisory board participation from Biogen, Bayer, Merck Serono, Novartis, Roche, and Sanofi-Genzyme.
